Avanos Medical, Inc. ( AVNS ) Nowojorska Giełda Papierów Wartościowych

Cena: 11.7 ( 4.84% )

Aktualizacja 08-22 21:59
Nowojorska Giełda Papierów Wartościowych
Branża: Medical - Devices
Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna

Notowania:

Opis firmy:

Avanos Medical, Inc., firma zajmująca się technologią medyczną, koncentruje się na dostarczaniu rozwiązań urządzeń medycznych w Ameryce Północnej, Europie, na Bliskim Wschodzie, Afryce, Azji i Ameryce Łacińskiej. Oferuje portfolio produktów do opieki przewlekłej, które obejmują produkty zdrowotne trawienne, takie jak dojeżdżające rurki dożylne, roztwory karmienia pacjentów z Corpak oraz neomed roztwory karmienia noworodka i pediatryczne; oraz produkty zdrowotne oddechowe, takie jak zamknięte systemy ssącego dróg oddechowych i inne urządzenia do zarządzania dróg oddechowych pod markami Ballard, MicroFuff i EndoClear. Firma dostarcza również portfolio nieopioidowych roztworów bólowych, w tym produkty ostrej bólu, takie jak ON-Q i ambitowe pompy bólu chirurgicznego, zimne i kompresyjne systemy terapii; oraz interwencyjne roztwory bólu, które oferują minimalnie inwazyjne terapie bólu, takie jak terapia bólu chłodnego. Wymaga swoich produktów bezpośrednio szpitalom i innym świadczeniodawcom, placówom opieki zdrowotnej i innym klientom użytkowników końcowych, a także przez innymi dystrybutorami hurtowymi. Firma była wcześniej znana jako Halyard Health, Inc. i zmieniła nazwę na Avanos Medical, Inc. w czerwcu 2018 r. Avanos Medical, Inc. został zarejestrowany w 2014 roku i ma siedzibę w Alpharetta w stanie Georgia.

Informacje o spółce:
Sektor: Zdrowie
Branża: Medical - Devices
Zatrudnienie: 3 771
Giełda: Nowojorska Giełda Papierów Wartościowych
Ilość akcji w obrocie: 85.56956
Ilość akcji: Brak danych
Debiut giełdowy: 2014-10-21
WWW: https://avanos.com
CEO: Mr. Michael C. Greiner CPA
Adres: 5405 Windward Parkway
Siedziba: 30004 Alpharetta
ISIN: US05350V1061
Wskaźniki finansowe
Kapitalizacja (USD) 542 909 250
Aktywa: 1 656 200 000
Cena: 11.7
Wskaźnik Altman Z-Score: 1.6
Słaby (wysokie ryzyko bankructwa)
Dywidenda: 0
P/E: -1.2
Ilość akcji w obrocie: 86%
Średni wolumen: 550 888
Ilość akcji 46 402 500
Wskaźniki finansowe
Przychody TTM 681 500 000
Zobowiązania: 426 500 000
Przedział 52 tyg.: 9.303 - 25.36
Piotroski F-Score: 6
Umiarkowany (średnia jakość finansowa)
EPS: -10.0
P/E branży: 29.9
Beta: 0.925
Raport okresowy: 2025-10-29
WWW: https://avanos.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. Michael C. Greiner Senior Vice President, Chief Financial Officer & Chief Transformation Officer 986 416 1973
Mr. Kerr W. Holbrook Senior Vice President & Chief Commercial Officer 747 614 1967
Ms. Mojirade James Senior Vice President, General Counsel & Corporate Secretary 728 665 1967
Mr. Joseph F. Woody Chief Executive Officer & Director 2 213 877 1966
Mr. David Crawford Vice President of FP&A and Investor Relations and Treasurer 0 0
Ms. Michelle Scharfenberg Senior Vice President and Chief Ethics & Compliance Officer 0 0
John W. Cato Vice President of Human Resources 0 0
Mr. Lee Burnes Senior Vice President of Global R&D, Clinical and Medical Affairs 0 0
Mr. Scott Galovan Vice President of Strategy & Corporate Development 0 0
Mr. John Joseph Hurley Principal Accounting Officer & Controller 0 0
Lista ETF z ekspozycją na akcje Avanos Medical, Inc.
Symbol ETF Ilość akcji Wartość
IJR 2 895 586 32 343 696
IWM 1 129 739 12 619 179
VB 536 570 6 567 616
IJS 458 099 5 116 968
CALF 447 420 4 997 681
IWN 407 696 4 553 960
SPSM 394 907 4 619 960
VBR 342 448 4 191 563
DFAT 293 398 3 277 255
SLYV 264 497 3 126 672
VTWO 228 196 2 793 119
SCHA 219 517 2 535 156
FESM 206 456 2 479 536
DFSV 182 997 2 044 076
FNDA 173 237 1 996 670
VIOO 152 999 1 872 707
VHT 145 002 1 774 824
DFAS 127 473 1 423 873
XHE 124 488 1 498 644
XMEM.L 106 336 90 008 219
DBX1.DE 106 336 1 040 132
XMMD.L 106 336 1 187 772
AVSC 96 279 1 123 575
VIOV 93 932 1 149 727
PRFZ 93 110 1 086 593
VFVA 87 897 1 075 859
RZV 86 829 1 013 294
DFAC 76 432 853 745
IUS3.DE 74 491 727 885
IDP6.L 74 491 832 059
ISP6.L 74 491 629 769
R2SC.L 72 204 638 529
R2US.L 72 204 842 620
ZPRR.DE 72 204 737 882
ITOT 62 840 701 927
RWJ 60 198 702 510
PSCH 44 337 517 412
GSSC 42 323 519 726
VVL.TO 36 793 614 497
WLDS.L 33 757 285 396
WSML.L 33 757 377 069
IUSN.DE 33 757 329 860
HTEC 33 315 0
PSC 31 888 356 188
VTWV 29 560 361 814
EES 29 418 328 599
XRS2.DE 26 116 255 454
XRSU.L 26 116 291 714
XRSG.L 26 116 22 105 870
SMLV 23 822 281 076
VFMF 23 251 284 592
RSSL 22 877 255 536
DX2D.DE 22 739 222 421
XLPE.L 22 733 19 242 549
FHLC 19 379 232 741
IJR.AX 16 388 295 971
SMMV 14 865 173 474
JPSE 14 141 157 954
IWV 12 508 139 713
VFQY 10 011 122 534
ZPRV.DE 9 917 88 280
USSC.L 9 917 100 811
AVUS 9 112 106 337
SPTM 9 031 105 607
DFAU 8 382 93 626
XSU.TO 7 777 125 361
QVMS 7 618 88 902
CAFG 5 558 62 082
SQLV 5 116 59 703
SXRG.DE 4 632 45 266
CUSS.L 4 632 51 744
CUS1.L 4 632 39 164
CSUSS.MI 4 632 45 266
UWM 4 535 50 655
DCOR 3 960 44 233
VTHR 3 892 47 638
URTY 3 754 41 932
XJR 3 627 42 327
OMFS 3 028 35 336
DFSU 2 900 32 393
TILT 2 310 25 802
ISCB 2 037 22 756
XUU.TO 2 000 32 240
XSMC.TO 1 635 26 357
XSMH.TO 1 512 24 380
DXUV 1 509 16 855
FNDB 1 437 16 658
VLU 1 351 15 852
AFSM 1 081 12 788
SPGM 1 054 12 329
SAA 853 9 528
XGRO.TO 756 12 180
AVSU 656 7 655
ESIX 354 4 154
XBAL.TO 348 5 607
XUH.TO 295 3 446
EBIT 205 2 392
HDG 54 603
XCNS.TO 27 439
XTR.TO 12 139
MMTM 5 57
SC0K.DE 0 41 594
USML.L 0 70 270
PZW.TO 0 5 080
USFM.L 0 0
RTYS.L 0 47 471
USUE.DE 0 0
Wiadomości dla Avanos Medical, Inc.
Tytuł Treść Źródło Aktualizacja Link
Avanos Medical (AVNS) International Revenue in Focus: Trends and Expectations Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock. zacks.com 2025-05-13 14:22:18 Czytaj oryginał (ang.)
New Strong Sell Stocks for May 9th AVNS, BCC and AMPY have been added to the Zacks Rank #5 (Strong Sell) List on May 9, 2025. zacks.com 2025-05-09 11:55:31 Czytaj oryginał (ang.)
AVNS Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down Strength in Avanos' SNS segment drives its first-quarter 2025 performance despite global macroeconomic challenges. zacks.com 2025-05-07 17:50:34 Czytaj oryginał (ang.)
Avanos Medical, Inc. (AVNS) Q1 2025 Earnings Call Transcript Avanos Medical, Inc. (NYSE:AVNS ) Q1 2025 Earnings Conference Call May 6, 2025 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy and Corporate Development Dave Pacitti - Chief Executive Officer Jason Pickett - Interim Chief Financial Officer and Treasurer Conference Call Participants Rick Wise - Stifel Daniel Stauder - Citizens JMP Operator Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos First Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Tuesday, May 6, 2025. seekingalpha.com 2025-05-06 18:38:14 Czytaj oryginał (ang.)
Avanos Medical (AVNS) Q1 Earnings and Revenues Top Estimates Avanos Medical (AVNS) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.22 per share a year ago. zacks.com 2025-05-06 13:25:57 Czytaj oryginał (ang.)
Avanos Medical, Inc. Announces First Quarter 2025 Results ALPHARETTA, Ga. , May 6, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2025 financial results. prnewswire.com 2025-05-06 11:00:00 Czytaj oryginał (ang.)
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results ALPHARETTA, Ga. , April 28, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2025 on Tuesday, May 6 at 9 a.m. prnewswire.com 2025-04-28 11:47:00 Czytaj oryginał (ang.)
AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK Avanos takes direct control of MIC-KEY sales in the UK, enhancing market presence, customer engagement and service efficiency, starting July 2025. zacks.com 2025-04-03 12:55:34 Czytaj oryginał (ang.)
Avanos Expands Direct Operations for MIC-KEY* Enteral Feeding Products in the UK starting July 2025 ZAVENTEM, Belgium , April 2, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) a global medical technology company, today announced that it will take direct responsibility for the sales and distribution of its MIC-KEY enteral feeding products in the United Kingdom, effective 25 July 2025. This strategic move reflects Avanos' commitment to prioritizing customer needs, enhancing product availability into the future, and providing a seamless experience for healthcare providers and patients. prnewswire.com 2025-04-02 11:00:00 Czytaj oryginał (ang.)
New Strong Sell Stocks for March 24th AVNS, AIRS and AMPH have been added to the Zacks Rank #5 (Strong Sell) List on March 24, 2025. zacks.com 2025-03-24 08:30:22 Czytaj oryginał (ang.)
New Strong Sell Stocks for March 18th AVNS, CARS and CABO have been added to the Zacks Rank #5 (Strong Sell) List on March 18, 2025. zacks.com 2025-03-18 11:00:29 Czytaj oryginał (ang.)
Avanos Medical Announces Appointment of David Pacitti as Chief Executive Officer ALPHARETTA, Ga. , March 17, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of David Pacitti as its new chief executive officer, effective April 14, 2025. prnewswire.com 2025-03-17 09:30:00 Czytaj oryginał (ang.)
New Strong Sell Stocks for March 3rd AVNS, CSX and STZ have been added to the Zacks Rank #5 (Strong Sell) List on March 3, 2025. zacks.com 2025-03-03 09:50:23 Czytaj oryginał (ang.)
AVNS Stock Gains Post Q4 Earnings & Revenue Beat, Margins Contract Strength in Avanos' Digestive Health segment drives its fourth-quarter 2024 performance despite global macroeconomic challenges. zacks.com 2025-02-27 12:46:26 Czytaj oryginał (ang.)
Avanos Medical Inc. (AVNS) Q4 2024 Earnings Call Transcript Avanos Medical Inc. (NYSE:AVNS ) Q4 2024 Earnings Conference Call February 26, 2025 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy & Corporate Development Michael Greiner - Interim Chief Executive Officer Conference Call Participants Danny Stauder - Citizens GMP Operator Good morning ladies and gentlemen. Welcome to the Avanos Fourth Quarter 2024 Earnings Call. seekingalpha.com 2025-02-26 14:41:05 Czytaj oryginał (ang.)
Avanos Medical (AVNS) Q4 Earnings and Revenues Surpass Estimates Avanos Medical (AVNS) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.40 per share. This compares to earnings of $0.36 per share a year ago. zacks.com 2025-02-26 11:25:29 Czytaj oryginał (ang.)
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2024 Results ALPHARETTA, Ga. , Feb. 26, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2024 results. prnewswire.com 2025-02-26 09:00:00 Czytaj oryginał (ang.)
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2024 Financial Results ALPHARETTA, Ga. , Feb. 19, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2024 on Wednesday, Feb. 26 at 9 a.m. prnewswire.com 2025-02-19 10:54:00 Czytaj oryginał (ang.)
Avanos Medical (AVNS) Soars 7.2%: Is Further Upside Left in the Stock? Avanos Medical (AVNS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term. zacks.com 2025-01-28 12:16:28 Czytaj oryginał (ang.)
Reasons to Hold Avanos Medical Stock in Your Portfolio Now AVNS' strong product line and focus on R&D raise optimism about the stock. zacks.com 2025-01-23 10:50:22 Czytaj oryginał (ang.)
Avanos Medical, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference ALPHARETTA, Ga. , Jan. 6, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will present at the 43rd  Annual J.P. prnewswire.com 2025-01-06 10:54:00 Czytaj oryginał (ang.)
New Strong Sell Stocks for December 11th AVNS, BATRK and ELV have been added to the Zacks Rank #5 (Strong Sell) List on December 11, 2024. zacks.com 2024-12-11 06:50:18 Czytaj oryginał (ang.)
Avanos Medical, Inc. to Present at the Stifel 2024 Healthcare Conference ALPHARETTA, Ga. , Nov. 12, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will participate in an analyst-led fireside chat at the Stifel 2024 Healthcare Conference at the Lotte New York Palace in New York on Tuesday, Nov. 19 at approximately 3:35 p.m. prnewswire.com 2024-11-12 14:07:00 Czytaj oryginał (ang.)
ON-Q* Elastomeric Infusion Pump and ambIT* Disposable Electronic Infusion Pump to Receive Separate Payment Under NOPAIN Act Starting January 1, 2025 ALPHARETTA, Ga. , Nov. 11, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) announced today that the Centers for Medicare and Medicaid Services (CMS) has issued its final Medicare Hospital Outpatient Prospective Payment System (OPPS) and Medicare Ambulatory Surgical Center (ASC) Payment System rule for 2025. prnewswire.com 2024-11-11 11:38:00 Czytaj oryginał (ang.)
Avanos Medical, Inc. to Present at the UBS Healthcare Conference 2024 ALPHARETTA, Ga. , Nov. 8, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will participate in a fireside chat at the UBS 2024 Healthcare Conference on Tues. prnewswire.com 2024-11-08 18:16:00 Czytaj oryginał (ang.)
Avanos Medical Launches New CORGRIP® SR Advancement to reduce dislodgement in feeding tube retention systems ALPHARETTA, Ga. , Nov. 5, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced the launch of its newly designed CORGRIP SR Nasogastric/Nasointestinal Tube Retention System, further expanding its comprehensive Enteral Feeding portfolio. prnewswire.com 2024-11-05 09:00:00 Czytaj oryginał (ang.)
Are Investors Undervaluing Avanos Medical (AVNS) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2024-10-31 12:45:34 Czytaj oryginał (ang.)
Avanos Q3 Earnings Meet Estimates, Sales Miss, Gross Margin Contracts Avanos Medical, Inc. AVNS reported third-quarter 2024 adjusted earnings per share (EPS) from continuing operations of 36 cents, up 20% year over year. The bottom line met the Zacks Consensus Estimate. zacks.com 2024-10-31 11:46:27 Czytaj oryginał (ang.)
Avanos Medical Inc. (AVNS) Q3 2024 Earnings Call Transcript Avanos Medical Inc. (NYSE:AVNS ) Q3 2024 Results Conference Call October 30, 2024 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy & Corporate Development Gary Blackford - Chairman Michael Greiner - Senior VP, CFO & Chief Transformation Officer Conference Call Participants Kristen Stewart - CL King Danny Stauder - Citizens JMP Operator Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos Third Quarter 2024 Earnings Call. [Operator Instructions] This call is being recorded on Wednesday, October 30, 2024. seekingalpha.com 2024-10-30 17:28:07 Czytaj oryginał (ang.)
Avanos Medical (AVNS) Q3 Earnings Meet Estimates Avanos Medical (AVNS) came out with quarterly earnings of $0.36 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.30 per share a year ago. zacks.com 2024-10-30 11:01:33 Czytaj oryginał (ang.)
Avanos Medical, Inc. Announces Third Quarter 2024 Results, retirement of CEO ALPHARETTA, Ga. , Oct. 30, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2024 financial results and announced the retirement of its CEO, Joe Woody. prnewswire.com 2024-10-30 08:45:00 Czytaj oryginał (ang.)
Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2024 Financial Results ALPHARETTA, Ga. , Oct. 23, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2024 on Wednesday, Oct. 30 at 9 a.m. prnewswire.com 2024-10-23 10:19:00 Czytaj oryginał (ang.)
Avanos Medical (AVNS) Upgraded to Strong Buy: What Does It Mean for the Stock? Avanos Medical (AVNS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). zacks.com 2024-10-17 17:01:16 Czytaj oryginał (ang.)
Should Value Investors Buy Avanos Medical (AVNS) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2024-10-09 14:45:22 Czytaj oryginał (ang.)
Reasons to Add Avanos Medical Stock in Your Portfolio Now AVNS's strong product line and focus on R&D raise optimism about the stock. zacks.com 2024-10-03 17:51:11 Czytaj oryginał (ang.)
Are Investors Undervaluing Avanos Medical (AVNS) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2024-09-19 14:41:15 Czytaj oryginał (ang.)
Why Avanos Medical (AVNS) is a Top Momentum Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com 2024-09-13 14:56:16 Czytaj oryginał (ang.)
Avanos Medical Stock May Gain From Brand Partnership With NFL AVNS' GAME READY announces a paid partnership with NFL defensive end and San Francisco 49ers star, Nick Bosa. zacks.com 2024-09-12 18:10:15 Czytaj oryginał (ang.)
Avanos Medical, Inc. to Present at the 2024 CL King Annual Best Ideas Conference ALPHARETTA, Ga. , Sept. 9, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president, chief financial officer, and chief transformation officer will participate in a fireside chat at CL King's virtual 22nd Annual Best Ideas Conference 2024 on Mon. prnewswire.com 2024-09-09 14:54:00 Czytaj oryginał (ang.)
Is Avanos Medical (AVNS) Stock Undervalued Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2024-08-22 14:46:33 Czytaj oryginał (ang.)
Should Value Investors Buy Avanos Medical (AVNS) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2024-08-05 14:46:25 Czytaj oryginał (ang.)